Can charcoal hemoperfusion treatment be an option for pediatric MIS‐C patients? A single‐center experience in a tertiary pediatric intensive care unit

Introduction Multisystem inflammatory syndrome in children (MIS‐C) is a hyper‐inflammatory disorder that develops following SARS‐CoV‐2 infection and has clinical signs that overlap with Kawasaki disease. Immunomodulatory treatments can be used in these patients. One of the alternative treatments rep...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical apheresis 2022-10, Vol.37 (5), p.489-496
Hauptverfasser: Varol, Fatih, Guney Sahin, Ebru, Cengiz, Mehmet, Kilic, Aziz, Altas, Zeynep Meva, Guven, Sirin, Çam, Halit
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!